C260-3120 Screening compound: 2-{3-[3-(cyclohexanesulfonyl)propyl]-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl}-N-(4-ethoxyphenyl)acetamide

C260-3120 Screening compound: 2-{3-[3-(cyclohexanesulfonyl)propyl]-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl}-N-(4-ethoxyphenyl)acetamide
C260-3120 Screening compound: 2-{3-[3-(cyclohexanesulfonyl)propyl]-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl}-N-(4-ethoxyphenyl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C260-3120
2-{3-[3-(cyclohexanesulfonyl)propyl]-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl}-N-(4-ethoxyphenyl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C260-3120

Molecular Formula

C27H33N3O6S (C27 H33 N3 O6 S)

Compound Name

2-{3-[3-(cyclohexanesulfonyl)propyl]-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl}-N-(4-ethoxyphenyl)acetamide

IUPAC name

2-{3-[3-(cyclohexanesulfonyl)propyl]-24-dioxo-1234-tetrahydroquinazolin-1-yl}-N-(4-ethoxyphenyl)acetamide

SMILES

CCOc(cc1)ccc1NC(CN(c(cccc1)c1C(N1CCCS(C2CCCCC2)(=O)=O)=O)C1=O)=O

InChI

InChI=1S/C27H33N3O6S/c1-2-36-21-15-13-20(14-16-21)28-25(31)19-30-24-12-7-6-11-23(24)26(32)29(27(30)33)17-8-18-37(34,35)22-9-4-3-5-10-22/h6-7,11-16,22H,2-5,8-10,17-19H2,1H3,(H,28,31)

InChI Key

AVURRDLMLNZING-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14739120

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

527.64

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.067

Distribution Coefficient, logD

4.067

Water Solubility, LogSw

-4.04

Polar Surface Area

90.747

Acid Dissociation Constant (pKa)

12.52

Base Dissociation Constant (pKb)

4.61

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

44.40

C260-3120 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Human Proteases Annotated Library (2868 compounds)

Regenerative Medicine Focused Library (23016 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds

References: we are preparing a list of scientific research reports with C260-3120 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C260-3120?
Check Price and Availability of C260-3120, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C260-3120 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C260-3120
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C260-3120
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C260-3120 available by request